Biliary dyskinesia in therapeutic practice

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Pain in the right hypochondrium is one of the most frequent complaints in patients with diseases of the gallbladder and biliary tract. In recent years, in developed countries, there has been a tendency to increase the frequency of gallbladder diseases. According to statistics, every tenth person experiences unpleasant sensations in the upper abdomen after eating fatty, fried, salted and smoked food, as well as after drinking alcohol or after psychoemotional and physical exertion. The most common diseases of the gallbladder and biliary tract are biliary dyskinesia.

Biliary dyskinesia is a functional disease caused by uncoordinated and untimely contraction of the gallbladder, bile ducts and Oddi sphincter. Pain with dyskinesia is described by the term "biliary pain": localized in the right hypochondrium, lasts about 30 minutes, there are often repeated attacks and even at night, sometimes nausea and vomiting occur, which does not bring relief, there is a feeling of bitterness in the mouth. Traditionally, this pathology of the gallbladder was divided into hypoand hyperkinetic types, which differed in their manifestations.

It should be noted that long-term functional disorders eventually lead to organic lesions. For example, with the hypokinetic type, there is a violation of the properties of bile, its ability to form stones increases, which leads to the development of cholelithiasis.

This article is devoted to the etiology, pathogenesis, clinical picture and treatment of JMP, as well as the use of the drug Hilak Forte in intestinal dysbiosis as a result of biliary tract disorders.

Full Text

Restricted Access

About the authors

V. V. Skvortsov

Volgograd State Medical University, Ministry of Health of Russia

Author for correspondence.
Email: vskvortsov1@ya.ru
ORCID iD: 0000-0002-2164-3537

Doctor of Medical Sciences, Professor

Russian Federation, Volgograd

B. N. Levitan

Astrakhan State Medical University, Ministry of Health of Russia

Email: vskvortsov1@ya.ru

Doctor of Medical Sciences, Professor

Russian Federation, Astrakhan

D. N. Emelyanov

Volgograd State Medical University, Ministry of Health of Russia

Email: vskvortsov1@ya.ru

Candidate of Medical Sciences

Russian Federation, Volgograd

E. M. Skvortsova

Volgograd State Medical University, Ministry of Health of Russia

Email: vskvortsov1@ya.ru
Russian Federation, Volgograd

References

  1. Ивашкин В.Т., Маев И.В., Шульпекова Ю.О. и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению дискинезии желчевыводящих путей. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018; 28 (3): 63–80 [Ivashkin V.T., Mayev I.V., Shulpekova Yu.O. et al. Diagnostics and treatment of biliary dyskinesia: clinical guidelines of the Russian gastroenterological Association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018; 28 (3): 63–80 (in Russ.)]. doi: 10.22416/1382-4376-2018-28-3-63-80
  2. Полунина Т.Е. Дискинезия желчевыводящих путей. Римский консенсус IV. Терапия. 2017; 6 (16): 16–8 [Polunina T.E. Biliary dysfunction. Rome consensus IV. Therapy. 2017; 6 (16): 16–8 (in Russ.)].
  3. Cotton P.B., Elta G.H., Carter C.R., et al. Gallbladder and Sphincter of Oddi Disorders. Gastroenterology. 2016; 150: 1420–9. doi: 10.1053/j.gastro.2016.02.033
  4. Буеверов А.О. Хронические заболевания желчного пузыря и желчевыводящих путей. Краткое руководство для практикующих врачей. М.: Медицинское информационное агентство, 2015; 144 с. [Bueverov A.O. Khronicheskie zabolevaniya zhelchnogo puzyrya i zhelchevyvodyashchikh putei. Kratkoe rukovodstvo dlya praktikuyushchikh vrachei. M.: Meditsinskoe informatsionnoe agentstvo, 2015; 144 р. (in Russ.)].
  5. Wilcox C.M. Sphincter of Oddi dysfunction Type III: New studies suggest new approaches are needed. World J Gastroenterol. 2015; 21 (19): 5755–61. doi: 10.3748/wjg.v21.i19.5755
  6. Yaghoobi M., Pauls Q., Durkalski V. et al. Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study. Endoscopy. 2015; 47 (10): 884–90. doi: 10.1055/s-0034-1392418
  7. Евтюхин И.Ю., Рязанова С.В., Дедов Д.В. и др. Сопоставление параметров качества жизни в отдаленном периоде интервенционного лечения больных ишемической болезнью сердца. Современные проблемы науки и образования. 2015; 6: 145 [Evtyukhin I.Y., Ryazanova S.V., Dedov D.V. et al. Comparison of quality-of-life parameters in the long-term period of interventional treatment in patients with coronary heart disease. Modern problems of science and education. 2015; 6: 145 (in Russ.)]. doi: 10.17513/spno.23336
  8. Ардатская М.Д. Функциональные расстройства билиарного тракта: проблемы диагностики и лечения. Фарматека. 2012; 2: 71–7 [Ardatskaya M.D. Functional Disorders Of The Biliary Tract: Problems Of Diagnosis And Treatment. Farmateka. 2012; 2: 71–7 (in Russ.)].
  9. Яковенко Э.П., Агафонова Н.А., Иванов А.Н. и др. Абдоминальные боли: от патогенеза к лечению. Фарматека. 2015; 2: 89–95 [Yakovenko E.P., Agafonova N.A., Ivanov A.N. et al. Abdominal pain: from pathogenesis to treatment. Farmateka. 2015; 2: 89–95 (in Russ.)].
  10. Вялов С.С. Холецистит некалькулезный хронический. Гастроэнтерология: практическое руководство. М.: МЕДпрессинформ, 2012; с. 46–9 [Vyalov S.S. Kholetsistit nekal'kuleznyi khronicheskii. Gastroenterologiya: prakticheskoe rukovodstvo. M.: MEDpressinform, 2012; s. 46–9 (in Russ.)].
  11. Панцырев Ю.М., Шаповальянц С.Г., Чернякевич С.А. Функциональные расстройства сфинктера Одди после холецистэктомии. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2011; 21 (3): 28–34 [Pantsyrev Yu.M., Shapoval’yants S.G., Chernyakevich S.A. et al. Post-cholecystectomy functional disorders of the sphincter of Oddi after. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2011; 21 (3): 28–34 (in Russ.)].
  12. Джоши Д., Наглядная гепатология. Учебное пособие. Пер. с англ. Под ред. Ч.С. Павлова. М.: ГЭОТАР-Медиа, 2018; 168 с. [Deepak J. Hepatology at a glance. Uchebnoe posobie. Transl. from Engl. Pod red. Ch.S. Pavlov. M.: GEOTAR-Media, 2018; 168 h. (in Russ.)].
  13. Ивашкин В.Т., Маев И.В., Баранская Е.К., и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению желчнокаменной болезни. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2016; 26 (3): 64–80 [Ivashkin V.T., Mayev I.V., Baranskaya Y.K., et al. Gallstone disease diagnosis and treatment: guidelines of the Russian gastroenterological association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016; 26 (3): 64–80 (in Russ.)]. doi: 10.22416/1382-4376-2016-26-3-64-80
  14. Селиверстов П.В., Куценко В.П., Иванюк Е.С. и др. Возможности диагностики, лечения и профилактики функциональных заболеваний желчного пузыря и сфинктера Одди. Врач. 2023; 34 (9): 65–71 [Seliverstov P., Kutsenko V., Ivanyuk E. et al. Possibilities of diagnosis, treatment and prevention of functional diseases of the gallbladder and sphincter of Oddi. Vrach. 2023; 34 (9): 65–71 (in Russ.)]. doi: 10.29296/25877305-2023-09-13
  15. Бакулин И.Г., Авалуева Е.Б., Серкова М.Ю. и др. Билиарный сладж: патогенез, этиология и лекарственная терапия. Тер арх. 2021; 93 (2): 179–86 [Bakulin I.G., Avalueva E.B., Serkova M.U. et al. Biliary sludge: pathogenesis, etiology and drug therapy. Ter Arkh. 2021; 93 (2): 179–86 (in Russ.)]. doi: 10.26442/00403660.2021.02.200638
  16. Авалуева Е.Б., Ситкин С.И., Бакулин И.Г. и др. Билиарный сладж и желчнокаменная болезнь: диагностика, лечение и профилактика: монография. М.: Прима Принт, 2023; 104 с. [Avalueva E.B., Sitkin S.I., Bakulin I.G. et al. Biliarnyi sladzh i zhelchnokamennaya bolezn': diagnostika, lechenie i profilaktika: monografiya. M.: Prima Print, 2023; 104 s. (in Russ.)]
  17. Цуканов В.В., Тонких Ю.Л., Васютин А.В. Рекомендации по ведению больных с функциональными расстройствами желчного пузыря и сфинктера Одди. Медицинский совет. 2017; 11: 100–3 [Tsukanov V.V., Tonkikh Y.L., Vasyutin A.V. Recommendations for the management of patients with functional disorders of the gall bladder and sphincter of Oddi. Medical Council. 2017; 11: 100–3 (in Russ.)]. doi: 10.21518/2079-701X-2017-11-100-103
  18. Полубояринов П.А., Моисеева И.Я., Федоров А.В. и др. Астрагал шерстистоцветковый (Astragalus dasyanthus Pell.) – наиболее перспективный источник нетоксичного органического селена. Медицинская сестра. 2023; 6: 46–51 [Poluboyarinov P.A., Moiseeva I.Ya., Fedorov A.V. et al. Woolly-flowered astragalus (Astragalus dasyanthus Pell.) is the most promising source of non-toxic organic selenium. Meditsinskaya sestra. 2023; 25 (6): 46–51 (in Russ.)]. doi: 10.29296/25879979-2023-06-09
  19. Полубояринов П.А., Елистратов Д.Г. Исследование биофортификации растений астрагала шерстистоцветкового (Astragalus dasyanthus Pall.) аминокислотой L-селеноцистином. Вопросы биологической, медицинской и фармацевтической химии. 2019; 22 (12): 64 [Poluboyarinov P.A., Elistratov D.G. Study of biofortification of Astragalus dasyanthus Pall. plants with the amino acid L-selenocystin. Problems of Biological Medical and Pharmaceutical Chemistry. 2019; 22 (12): 64 (in Russ.)].
  20. Соколов С.Я., Замотаев И.П. Справочник по лекарственным растениям (Фитотерапия). 2-е изд., стереотипн. М.: Медицина, 1988; 464 с. [Sokolov S.Ya., Zamotaev I.P. Handbook of medicinal plants (Phytotherapy). 2nd ed., stereotypical. M.: Medicine, 1988; 464 p. (in Russ.)].
  21. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995; 125 (6): 1401–12. doi: 10.1093/jn/125.6.1401
  22. Mitsuoka T., Hidaka H., Eida T. Effect of fructo-oligosaccharides on intestinal microflora. Nahrung. 1987; 31 (5–6): 427–36. doi: 10.1002/food.19870310528
  23. Marteau P., Jacobs H., Cazaubiel M. et al. Effects of chicory inulin in constipated elderly people: a double-blind controlled trial. Int J Food Sci Nutr. 2011; 62 (2): 164–70. doi: 10.3109/09637486.2010.527323
  24. Butzner J.D. et al. Butyrate enema therapy stimulates mucosal repair in experimental colitis in rat. Gut. 1996; 38 (4): 568–73. doi: 10.1136/gut.38.4.568
  25. Kobayashi H., Tan E.M., Fleming S.E. Sodium butyrate inhibits cell growth and stimulates p21WAF1/CIP1 protein in human colonic adenocarcinoma cells indipendently of p53 status. Nutr Cancer. 2003; 46 (2): 202–11. doi: 10.1207/S15327914NC4602_14
  26. Flamm G., Glinsmann W., Kritchevsky D., et al. Inulin and oligofructose as dietary fibre: a review of the evidence. Crit Rev Food Sci Nutr. 2001; 41 (5): 353–62. doi: 10.1080/20014091091841
  27. Чхве Тхэсоп. Лекарственные растения. М.: Медицина, 1987; 608 с. [Choi Taesop. Medicinal plants. M.: Medicine, 1987; 608 p. (in Russ.)].
  28. Касьянов Г.И., Сязин И.Е., Лугинин М.И. и др. Технология криообработки и криопереработки растительного сырья. Современные научные исследования и инновации. 2012; 3 [Электронный ресурс] [Kasyanov G.I., Syazin I.E., Luginin M.I. et al. Technology of cryoprocessing and cryoprocessing of plant raw materials. Modern scientific researches and innovations. 2012; 3 [Electronic resource] (in Russ.)]. URL: http://web.snauka.ru/issues/2012/03/10751 (access date: 10.26.2023)
  29. Осецкий А.И., Грищенко В.И., Гольцев А.Н. и др. Криогенные технологии в производстве фармацевтических, косметических, агротехнических препаратов и биологически активных пищевых добавок. Проблемы криобиологии. 2009; 19 (4): 488–99 [Ossetsky A.I., Grishchenko V.I., Goltsev A.N. et al. Cryogenic technologies in production of pharmaceutical, cosmetic, agrotechnical formulations and biologically active food additives. Problems of Cryobiology. 2009; 19 (4): 488–99 (in Russ.)].

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies